Please login to the form below
ENSEMBLE
This page shows the latest ENSEMBLE news and features for those working in and with pharma, biotech and healthcare.
J&J could launch its single-dose COVID-19 vaccine in March
The phase 3 ENSEMBLE trial was launched in collaboration with the US Department of Health and Human Services’ (HHS) Biomedical Advanced Research and Development Authority (BARDA) and the US National Institute ... In an interim analysis of results from
Latest news
-
J&J completes enrolment for late-stage COVID-19 vaccine trial
Last week, J&J announced that it would decrease the size of the ENSEMBLE trial after cases surged across the US. ... Interim results from the phase 1/2a ENSEMBLE trial demonstrated that the shot has a promising safety profile and immunogenicity after a
-
J&J trims the size of its phase 3 COVID-19 vaccine trial
We continue to anticipate that interim data from the ENSEMBLE trial will be available by the end of January,” J&J said in a statement. ... Interim results from the phase 1/2a ENSEMBLE trial demonstrated that the shot has a promising safety profile and
-
EMA launches rolling review of J&J’s COVID-19 vaccine
In an interim analysis of results from the ENSEMBLE phase 1/2a trial, J&J’s vaccine demonstrated a promising safety profile and immunogenicity after a single dose. ... The pharma giant is initiating the phase 3 ENSEMBLE trial in collaboration with the
-
J&J advances COVID-19 vaccine into second phase 3 trial
The ENSEMBLE 2 study will enrol participants in the UK, the US, France, Germany, Spain, Belgium, South Africa, Colombia and the Philippines. ... As part of this deal, the UK also agreed to co-fund the phase 3 ENSEMBLE 2 trial.
-
Both AZ and J&J set to resume US COVID-19 vaccine trials
In a separate announcement, J&J said that the Independent Data Safety Monitoring Board (DSMB) overseeing the pause of its phase 3 ENSEMBLE study recommended resuming trial recruitment.
More from news
Approximately 1 fully matching, plus 11 partially matching documents found.
Latest Intelligence
-
Stepping out
The ‘one-size-fits-all’ approach will not change behaviours.”. An ensemble performance. Naturally, patients are the focal point of behaviour change programmes.
-
Integrated thinking - it’s both art and science
While these guys may not sound as good together as the ensemble musical cast of Station to Station or “Heroes”, there's little doubt this approach represents a refreshing challenge to
-
Pharma deals during November 2012
230. Cipla Medpro / Cipla. Acquisition. Generics. 215. Ensemble Therapeutics / Boehringer Ingelheim.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Lead Copywriter
-
Competitive
-
Medical Editor
-
Competitive
-
Healthcare Account Director
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Senior Account Manager
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Pfizer introduces new logo in a ‘shift from commerce to science’
- New study identifies drugs that are safe to use in COVID-19 treatment
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Branding Science
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
